Application for the FDA submission was announced in April and the filing of a patent in May.
It would seem that as these events come to fruition, the share price will bounce out of the current trading pattern and head into new territory.
COVID obviously has effected business globally as priorities have been redirected elsewhere to protecting the health of all on the planet earth.
Time to be patient.
RHT Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
